A detailed history of Newbridge Financial Services Group, Inc. transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 6,000 shares of PACB stock, worth $10,980. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,000
Previous 6,000 -0.0%
Holding current value
$10,980
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 11, 2024

BUY
$1.36 - $3.65 $8,160 - $21,900
6,000 New
6,000 $8,000
Q2 2022

Jul 15, 2022

SELL
$4.02 - $10.43 $3,847 - $9,981
-957 Closed
0 $0
Q1 2022

Apr 26, 2022

BUY
$8.43 - $20.9 $4,703 - $11,662
558 Added 139.85%
957 $9,000
Q4 2021

Jan 19, 2022

BUY
$19.26 - $30.08 $7,684 - $12,001
399 New
399 $8,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $411M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.